Replies to post #439776 on Anavex Life Sciences Corp (AVXL)

[boi568]

If that were true, the 2b/3 trial would have had them as additional endpoints.

[crescentmotor]

Could it be that Anavex is now pressing for blarcamesine as a treatment solely for the agitation and insomnia of Alzheimer’s, instead of a treatment for the cognition pathologies of that disease?

No--AVXL can't "press" for Blarcamesine as a treatment for insomnia, etc. without conducting clinical trials for those indications.